Prognostic value of HALP score in non-small cell lung cancer (NSCLC) patients with first-line chemotherapy combined with immunotherapy: a real-world retrospective study

Current Medical Research and Opinion · Published 2026-07-31 · DOI 10.1080/03007995.2026.2709202

Authors (5)

Yaping Zhang, Keda Shao, Xiaodong Cao, Guifang Gu, Wenxian Wang

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Zhang, Y., Shao, K., Cao, X., et al. (2026). Prognostic value of HALP score in non-small cell lung cancer (NSCLC) patients with first-line chemotherapy combined with immunotherapy: a real-world retrospective study. Current Medical Research and Opinion. https://doi.org/10.1080/03007995.2026.2709202

Related articles